Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of Stock Option Activity

A summary of employees’ stock options activities during the year ended December 31, 2024 is as follows:

 

	Year ended
	December 31, 2024
	Number	Weighted average exercise price		Aggregate intrinsic value (in thousands)		Weighted average remaining contractual life (years)
Options outstanding as of January 1, 2024	573,430	$	7.564	$	21,627	0.962
Granted	—	$	—
Exercised	(570,064)	$	7.575
Forfeited and expired	—	$	—
Options outstanding and exercisable as of December 31, 2024	3,366	$	5.682	$	130	3.490

Schedule of Share-based Payment Arrangement, Restricted Stock Unit and Performance Stock Unit Activity

A summary of RSUs and PSUs for employees, consultants and non-employee directors of the Company for the year ended December 31, 2024 is as follows:

 

	Number of shares underlying outstanding RSUs and PSUs	Weighted-average grant date fair value
Unvested balance as of January 1, 2024	8,234,171	$	36.83
Granted	3,864,327	$	43.38
Vested	(3,224,561)	$	39.75
Forfeited	(1,231,445)	$	38.78
Unvested balance as of December 31, 2024	7,642,492	$	38.60

Schedule of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

 

	Year ended
	December 31,
	2024		2023		2022
Cost of revenues	$	5,192	$	7,221	$	10,720
Research and development	41,766		48,679		50,971
Sales and marketing	41,494		48,047		51,793
General and administrative	38,230		35,872		29,378
Total	$	126,682	$	139,819	$	142,862